Clinical Trial Update: Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous sural nerve grafting to the substantia nigra in patients with synucleinopathies, including Parkinson's disease and Multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Parkinson Disease

Snippet

Sponsor: Craig van Horne, MD, PhD | Conditions: Multiple System Atrophy, Parkinsons Disease | Phase 1 | Status: RECRUITING